Royalty Biz Seeks Toss Of Hedge Fund's Bid For Board Seats
Biotech licensing firm Innoviva Inc. urged a Delaware vice chancellor Thursday to grant a summary judgment denying activist hedge fund Sarissa Capital's demand for two new seats on Innoviva's board, saying...To view the full article, register now.
Already a subscriber? Click here to view full article